Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

NCT05553093 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Tirzepatide
DRUG: Insulin Glargine

Sponsor

Nanjing First Hospital, Nanjing Medical University